We are excited to announce that ExSURE PVT. LTD. has successfully raised a significant amount of funding as we continue our mission to revolutionize cancer treatment through innovative research and development. Specializing in exosome-based therapeutics, our startup is at the forefront of creating a groundbreaking chemotherapeutic drug-delivery platform designed to deliver anti-cancer drugs directly into tumor cells and relapse-causing cancer stem cells, all while minimizing damage to healthy cells. This unique mechanism of action stands to dramatically reduce chemotoxicity and the risk of cancer relapse, addressing a critical need in oncology care. Our recent funding will primarily be utilized to advance our platform from in vitro and ex-vivo validations to in vivo studies using SCID mice, an essential step in our development process. Having already shown promising results in various breast cancer cell lines and chemo-naive clinical samples, we are eager to progress further in validating our approach. Additionally, the funding will support our upcoming patent filing for our innovative formulation and methodologies that underpin the bioengineered drug-loaded targeted exosomes. Beyond our core research, ExSURE also offers a range of outsourcing services, including cell-culture-based assays and cancer stem cell-based experimentation, aimed at accelerating discovery in cancer research. As we look to the future, we are optimistic that our advancements in exosome technology can lead to more effective, personalized cancer treatment solutions. Stay tuned for more updates as we continue our journey towards making a meaningful impact in the fight against cancer!
Pioneering Cancer Therapeutics Startup, ExSURE PVT. LTD., Secures Funding for Next-Gen Drug-Delivery Platform
Biotechnology
Get the full ExSURE PVT. LTD. company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Laihua Online
Wuhan Laihua Information and Technology is an Internet leading source of information on educational opportunities for students to study in other countries especially in China. Either prospect is planning to come to China or is already in China for education (self-support or scholarship based) he will probably need one of the ranges of services we provide from Education, Translation, Notarization of legal documents to Internships & Jobs or Medical Tourism etc. It is a comprehensive directory of study abroad programs, including summer study abroad, service learning, intensive language programs and more. Wuhan Laihua Information and Technology first set out to fill the information gap between students with a desire to travel abroad to study and companies offering international programs.
$68.0M Series d
today
NEW ID
NEW ID is the latest subsidiary company of NEW, which has started up since August 2019 for a new digital contents/platform business domain. We are responsible for expanding the contents produced and acquired by NEW into various markets and creating our digital capabilities through partnering with a-lister digital content creators and providers in Korea.
